ABCL Stock Price
AbCellera Biologics Inc.
ABCL stock price is $12.37 (-1.90% on the day), giving AbCellera Biologics Inc. a market cap of $4.01B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ABCL Stock Overview
- Price
- $12.37
- Previous close
- $12.61
- Open
- $12.37
- Market cap
- $4.01B
- P/E ratio
- -27.4
- 52-week range
- $2.75 - $15.02
- 1-year price target
- $16.70
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 50
About AbCellera Biologics Inc.
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABCL | $12.37 | -1.9% | 3.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get AbCellera Biologics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW